• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Trex sales and net surge in 1996

Article

Acquisitions and higher product sales fed a boom in revenues andnet income for x-ray vendor Trex Medical in fiscal 1996 (end-September).A highlight for the Danbury, CT, firm was its Lorad division,which enjoyed a 35% increase in revenues thanks to strong

Acquisitions and higher product sales fed a boom in revenues andnet income for x-ray vendor Trex Medical in fiscal 1996 (end-September).A highlight for the Danbury, CT, firm was its Lorad division,which enjoyed a 35% increase in revenues thanks to strong salesof its stereotactic breast-biopsy systems.

For the year, Trex posted sales of $150.2 million, more thandouble last year's figure of $70.5 million. A good portion ofthe increase was due to the addition of revenues from BennettX-Ray, which was purchased in 1995 and contributed a full yearof revenues to Trex's fiscal 1996.

In addition to stereotactic biopsy sales, Lorad also benefitedfrom its new M-IV mammography system, which began shipping inquantity for the first time in the company's fourth quarter, accordingto Trex president and CEO Hal Kirshner.

Trex's net income figures were also impressive. The companyregistered a profit of $9.3 million for the year, compared withnet income of $3.6 million in fiscal 1995.

In addition to Lorad's growth, Bennett saw a 14% increase insales of general x-ray systems, while XRE enjoyed record bookingsfor its cardiac cath lab systems in the fourth quarter. Revenuesfrom Trex's most recent acquisition, Continental X-Ray, did notfigure significantly into Trex's fiscal 1996, as that acquisitionwas finalized in late September.

Recent Videos
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.